PubMed=9973437; DOI=10.4049/jimmunol.162.3.1739
Castelli C., Tarsini P., Mazzocchi A., Rini F., Rivoltini L., Ravagnani F., Gallino F., Belli F., Parmiani G.
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.
J. Immunol. 162:1739-1748(1999)

DOI=10.13130/grazia-giulia_phd2016-02-18
Grazia G.
Co-targeting of oncogenic and death receptors pathways in human melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic strategy.
Thesis PhD (2015), Universita degli studi di Milano, Italy

PubMed=25576923; DOI=10.18632/oncotarget.2995
Loria R., Bon G., Perotti V., Gallo E., Bersani I., Baldassari P., Porru M., Leonetti C., Di Carlo S., Visca P., Brizzi M.F., Anichini A., Mortarini R., Falcioni R.
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Oncotarget 6:2779-2793(2015)